CADRX
Price
$25.00
Change
-$0.16 (-0.64%)
Updated
Oct 7 closing price
Net Assets
1.34B
RGACX
Price
$85.45
Change
-$0.56 (-0.65%)
Updated
Oct 7 closing price
Net Assets
342.85B
Interact to see
Advertisement

CADRX vs RGACX

Header iconCADRX vs RGACX Comparison
Open Charts CADRX vs RGACXBanner chart's image
Columbia Large Cap Growth Opp Inst2
Price$25.00
Change-$0.16 (-0.64%)
VolumeN/A
Net Assets1.34B
American Funds Growth Fund of Amer R3
Price$85.45
Change-$0.56 (-0.65%)
VolumeN/A
Net Assets342.85B
CADRX vs RGACX Comparison Chart in %
View a ticker or compare two or three
VS
CADRX vs. RGACX commentary
Oct 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CADRX is a Buy and RGACX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGACX has more cash in the bank: 343B vs. CADRX (1.34B). RGACX pays higher dividends than CADRX: RGACX (0.07) vs CADRX (0.00). CADRX was incepted earlier than RGACX: CADRX (12 years) vs RGACX (23 years). RGACX (0.94) is less costly to investors than CADRX (0.80). CADRX is a more actively managed with annual turnover of: 35.00 vs. RGACX (25.00). CADRX has a lower initial minimum investment than RGACX: CADRX (0) vs RGACX (250). CADRX annual gain was more profitable for investors over the last year : 17.57 vs. RGACX (14.51). RGACX return over 5 years is better than : 40.62 vs. CADRX (-2.59).
CADRXRGACXCADRX / RGACX
Total Expense Ratio0.740.9479%
Annual Report Gross Expense Ratio0.800.9485%
Fund Existence12 years23 years-
Gain YTD11.32718.69761%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets1.34B343B0%
Annual Yield % from dividends0.000.07-
Returns for 1 year17.5714.51121%
Returns for 3 years83.2572.98114%
Returns for 5 years-2.5940.62-6%
Returns for 10 years28.7699.8229%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HNSBF4.58N/A
N/A
Hansa Medical AB
KSANF16.90N/A
N/A
Kansai Paint Co., Ltd.
SQZB0.03N/A
N/A
SQZ Biotechnologies Company
SFCO9.55N/A
N/A
Southern Financial Corp.
UPMMY25.97-0.51
-1.93%
UPM-Kymmene Corp.